Condition
Neutrophil-Lymphocyte Ratio
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05976204Completed
Prognostic Value of NLR, TLR, and ALC in Predicting ToF Primary Repair Outcome
NCT05750160Not ApplicableCompleted
Music Therapy on Neutrophyl Lymphocytes Ratio, Interleukin 6 and Interleukin 10 Levels of Burnout Syndrome
NCT05433870Completed
Inflammatory Biomarkers for the Diagnosis of oPRES
NCT05329311Completed
Enhanced Recovery After Thoracic Surgery
NCT04736290Unknown
NLR and PRL in Neurocognitive Disorders
Showing all 5 trials